ArticleCureus2026
Management of Inflammatory Myofibroblastic Tumor of Urinary Bladder With Partial Cystectomy: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory myofibroblastic tumors (IMTs) are rare mesenchymal neoplasms that can mimic malignant bladder tumors both clinically and radiographically. We report the case of a 46-year-old woman who presented with recurrent episodes of gross hematuria and clot retention. Imaging revealed a 6.2 cm bladder mass at the anterior dome without metastatic disease. She underwent transurethral resection, and pathology demonstrated a spindle cell neoplasm expressing anaplastic lymphoma kinase (ALK), desmin, and smooth muscle actin, while fluorescence in situ hybridization confirmed ALK gene rearrangement. Despite initial endoscopic management, persistent hematuria required a robotic-assisted partial cystectomy, which achieved complete resection with negative margins. The patient recovered well, and follow-up imaging and cystoscopy at six months demonstrated no recurrence. This case highlights the diagnostic and management challenges of bladder IMTs, which often present with features that overlap with other malignancies of the bladder. While generally considered tumors of intermediate biologic potential, complete surgical excision remains the cornerstone of management. Bladder-sparing approaches, such as partial cystectomy, are effective in select patients and offer excellent outcomes when negative margins are achieved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.